Testing for Divergent Strains


Support Future Events

Help keep these events free to the public.

About the Event

This webinar will address both the clinical and technical aspects of Galaxy Diangostic’s diagnostic options. Dr. Amanda Elam will provide a full overview of their tick-borne disease testing portfolio with the goal of educating patients and practitioners.

About the Guest

Dr. Amanda Elam is the President/CEO of Galaxy Diagnostics. She co-founded Galaxy Diagnostics in 2009 and continues to lead corporate strategy and business development activities. Dr. Elam is an entrepreneur and scholar with experience in life sciences and information technology markets. In addition to her leadership role at Galaxy Diagnostics, she holds a Diana Research Fellowship at Babson College where she conducts sponsored research studies for the Center for Women’s Entrepreneurial Leadership (CWEL). Dr. Elam holds a doctorate in Sociology from the University of North Carolina at Chapel Hill and has published extensively on the topic of business start-up and growth in top journals and global research reports. Her doctoral research on entrepreneurship was recognized by the Academy of Management for innovative thought leadership. Galaxy Diagnostics represents Dr. Elam’s first foray into the life sciences industry. As a highly regulated and complex industry, the life sciences provide countless illustrations of the barriers to innovation in healthcare and medicine. The challenges for entrepreneurs and business leaders today include finding better ways to build flexible, efficient organizations and processes to facilitate market innovation.

About the Sponsors

Project Lyme

Our mission is to eradicate the epidemic of tick-borne diseases through awareness and education, support of cutting-edge science, and advocacy for solutions to end the suffering. As a national Lyme disease non-profit, we aim to positively impact patients’ lives through our work.